AmoyDx® IDH1/2 PCR Panel
PCR
Inquiry
The AmoyDx ® IDH1/2 PCR Panel is a qualitative real-time PCR assay developed for the detection of 15 mutations in the IDH1 gene across exon 4, and IDH2 gene across exon 4, using DNA extracted from peripheral blood/bone marrow of acute myeloid leukemia patients or FFPE of glioma patients.
AmoyDx® IDH1/2 Panel - Superior Sensitivity Compared to Sanger Sequencing
To evaluate the clinical reliability of the AmoyDx® IDH1/2 PCR Panel, its performance was compared to Sanger sequencing using 949 samples, summarized in the table below.
AmoyDx® IDH1/2 Panel - Superior Sensitivity Compared to Sanger Sequencing
To evaluate the clinical reliability of the AmoyDx® IDH1/2 PCR Panel, its performance was compared to Sanger sequencing using 949 samples, summarized in the table below.
Detects 15 clinically relevant mutations in IDH1/2 exon 4, including R132H, R140Q, and R172K.
Detects mutations at as low as 1-2% VAF.
Results within 2.5 hours from DNA with robust quality controls
Pre-loaded format with automated result interpretation.
Kit Format
10 tests / kit
Inquiry